Iterative Health Expands GI Research Network with New Jersey Partnership
Event summary
- Iterative Health partners with Gastroenterology Associates of New Jersey to expand GI clinical research access.
- Two new research sites established in Toms River and Clifton, NJ, joining a global network of 110+ sites.
- GANJ's 28-location practice network integrates research into community GI care for over 9.5 million residents.
- Partnership focuses on inflammatory bowel disease (IBD), leveraging Iterative Health’s AI-powered innovation.
The big picture
This collaboration aligns with the trend of decentralizing clinical research into community healthcare networks, enhancing patient access to cutting-edge therapies. Iterative Health’s growing network of over 110 sites positions it as a key player in GI and hepatology clinical development, leveraging AI to streamline trial operations.
What we're watching
- Network Scalability
- Whether Iterative Health can sustain rapid site expansion while maintaining trial performance.
- Diverse Patient Reach
- How New Jersey’s demographic diversity impacts the representativeness of clinical trials.
- Therapeutic Focus
- The pace at which IBD research advances within community settings through this partnership.
Related topics